Precigen director plans $1.37M stock sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PRECIGEN, INC. (PGEN) is the issuer for which Jeffrey Kindler has filed a notice of proposed sale of restricted securities under Rule 144. The filing covers 185,000 shares of Common Stock, with an indicated aggregate market value of $1,372,700, to be sold through Goldman Sachs & Co. LLC on or after 08/26/2026. These shares were acquired from Precigen as compensation in the form of Restricted Stock Units on various grant dates between 03/09/2023 and 03/13/2026.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Units financial
aggregate market value financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for PRECIGEN, INC. (PGEN)?
AI-generated analysis. How Rhea-AI works. Not financial advice.